These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16326748)

  • 1. Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
    Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
    Nephrol Dial Transplant; 2006 Apr; 21(4):1087-8. PubMed ID: 16326748
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
    Tokunaga M; Tamura M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Fujimatsu S; Muta T; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Ther Apher Dial; 2009 Feb; 13(1):77-9. PubMed ID: 19379174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.
    Hirayama K; Kobayashi M; Hashimoto Y; Usui J; Shimizu Y; Hirayama A; Yoh K; Yamagata K; Nagase S; Nagata M; Koyama A
    Am J Kidney Dis; 2004 Jul; 44(1):57-63. PubMed ID: 15211438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
    Jones R; Shah S; MacMahon EE; Goldsmith DJ
    Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244
    [No Abstract]   [Full Text] [Related]  

  • 5. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.
    Tesar V; Masek Z; Rychlík I; Merta M; Bartůnková J; Stejskalová A; Zabka J; Janatková I; Fuciková T; Dostál C; Becvár R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1662-7. PubMed ID: 9681708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement.
    Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V
    Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission.
    Lydon EJ; Barisoni L; Belmont HM
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S144. PubMed ID: 19646364
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained monocyte activation in clinical remission of systemic vasculitis.
    Wikman A; Lundahl J; Jacobson SH
    Inflammation; 2008 Dec; 31(6):384-90. PubMed ID: 18846416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of ANCA-associated vasculitis.
    Langford CA
    N Engl J Med; 2003 Jul; 349(1):3-4. PubMed ID: 12840085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis und therapy of ANCA-associated vasculitis].
    Aries PM; Hellmich B; Gross WL
    Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mizoribine for relapsed proteinuria in an adult IgA nephropathy patient.
    Tokunaga M; Tamura M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Nakamata J; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Clin Nephrol; 2008 Nov; 70(5):445-6. PubMed ID: 19000548
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential immunosuppressive therapeutics to target small vessel vasculitis of the kidney.
    Williams JM
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1142-8. PubMed ID: 16312136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.